Our data presented in this report suggest CpG is working in the B78 model to activate tumor infiltrating macrophages, which agrees with previous publications that indicate CpG activates anti-tumor macrophages via IFN-dependent pathways [40]. Here, IFNA1 is linked to neoplasm.